Form D Reporting: Silicon Therapeutics $6.25 million Financing. Peiqi Sun Filed Oct 31 SEC Form

Silicon Therapeutics Llc - Peiqi Sun

Silicon Therapeutics Financing

Silicon Therapeutics Llc, Limited Liability Company just filed form D announcing $6.25 million equity financing. This is a new filing. Silicon Therapeutics was able to sell $6.25 million. That is 100.00% of the fundraising offer. The total financing amount was $6.25 million. The financing form was filed on 2016-10-31. The reason for the financing was: unspecified.

Silicon Therapeutics is based in Massachusetts. The company’s business is not disclosed. The D form was signed by Peiqi Sun President. The company was incorporated in 2016. The filler’s address is: 300 A Street, Boston, Ma, Massachusetts, 02110. Peiqi Sun is the related person in the form and it has address: C/O Silicon Therapeutics Llc, 300 A Street, Boston, Ma, Massachusetts, 02110. Link to Silicon Therapeutics Filing: 000168409516000002.

Analysis of Silicon Therapeutics Offering

On average, firms in the not disclosed sector, sell 67.77% of the total offering amount. Silicon Therapeutics sold 100.00% of the offering. Could this mean that the trust in Silicon Therapeutics is high? The average investment size for companies in all industries in our database is $3.05 million. The total amount raised is 104.90% bigger than the average for companies in the database. The minimum investment for this financing is set at $0. If you know more about the reasons for the fundraising, please comment below.

What is Form D? What It Is Used For

Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.

Why Fundraising Reporting Is Good For Silicon Therapeutics Also

The Form D signed by Peiqi Sun might help Silicon Therapeutics Llc’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment